U.S. flag

An official website of the United States government

NM_000391.4(TPP1):c.616C>T (p.Arg206Cys) AND Neuronal ceroid lipofuscinosis 2

Germline classification:
Pathogenic (5 submissions)
Review status:
2 stars out of maximum of 4 stars
criteria provided, multiple submitters, no conflicts
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV000002765.15

Allele description [Variation Report for NM_000391.4(TPP1):c.616C>T (p.Arg206Cys)]

NM_000391.4(TPP1):c.616C>T (p.Arg206Cys)

Gene:
TPP1:tripeptidyl peptidase 1 [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
11p15.4
Genomic location:
Preferred name:
NM_000391.4(TPP1):c.616C>T (p.Arg206Cys)
HGVS:
  • NC_000011.10:g.6617046G>A
  • NG_008653.1:g.7416C>T
  • NM_000391.4:c.616C>TMANE SELECT
  • NP_000382.3:p.Arg206Cys
  • LRG_830t1:c.616C>T
  • LRG_830:g.7416C>T
  • LRG_830p1:p.Arg206Cys
  • NC_000011.9:g.6638277G>A
  • NM_000391.3:c.616C>T
  • O14773:p.Arg206Cys
Protein change:
R206C; ARG206CYS
Links:
UniProtKB: O14773#VAR_009605; UniProtKB/Swiss-Prot: VAR_009605; OMIM: 607998.0006; dbSNP: rs28940573
NCBI 1000 Genomes Browser:
rs28940573
Molecular consequence:
  • NM_000391.4:c.616C>T - missense variant - [Sequence Ontology: SO:0001583]
Functional consequence:
Unknown function
Observations:
1

Condition(s)

Name:
Neuronal ceroid lipofuscinosis 2
Synonyms:
JANSKY-BIELSCHOWSKY DISEASE NEURONAL CEROID LIPOFUSCINOSIS, LATE INFANTILE; TPP1-Related Neuronal Ceroid-Lipofuscinosis
Identifiers:
MONDO: MONDO:0008769; MedGen: C1876161; Orphanet: 168491; Orphanet: 228349; Orphanet: 79264; OMIM: 204500

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV000022923OMIM
no assertion criteria provided
Pathogenic
(Feb 1, 2000)
germlineliterature only

PubMed (1)
[See all records that cite this PMID]

SCV000091197UniProtKB/Swiss-Prot
no classification provided
not providednot providednot provided

PubMed (2)
[See all records that cite these PMIDs]

SCV002094863Natera, Inc.
no assertion criteria provided
Pathogenic
(Mar 10, 2020)
germlineclinical testing

SCV002754481Foundation for Research in Genetics and Endocrinology, FRIGE's Institute of Human Genetics
criteria provided, single submitter

(ACMG Guidelines, 2015)
Pathogenicgermlineclinical testing

PubMed (1)
[See all records that cite this PMID]

SCV005060865Neuberg Centre For Genomic Medicine, NCGM
criteria provided, single submitter

(ACMG Guidelines, 2015)
Pathogenicgermlineclinical testing

PubMed (1)
[See all records that cite this PMID]

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlinenot providednot providednot providednot providednot providednot providedliterature only
not providedgermlineyes1not providednot providednot providednot providedclinical testing
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing
not providednot providednot providednot providednot providednot provided1not providedliterature only

Citations

PubMed

Prenatal testing for late infantile neuronal ceroid lipofuscinosis.

Berry-Kravis E, Sleat DE, Sohar I, Meyer P, Donnelly R, Lobel P.

Ann Neurol. 2000 Feb;47(2):254-7.

PubMed [citation]
PMID:
10665500

[Tripeptidyl peptidase 1 deficiency in neuronal ceroid lipofuscinosis. A novel mutation].

Bukina AM, Tsvetkova IV, Semiachkina AN, Il'ina ES.

Vopr Med Khim. 2002 Nov-Dec;48(6):594-8. Russian.

PubMed [citation]
PMID:
12698559
See all PubMed Citations (3)

Details of each submission

From OMIM, SCV000022923.6

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedliterature only PubMed (1)

Description

In a family with first-cousin parents, Berry-Kravis et al. (2000) demonstrated a 3664C-T transition in the CLN2 gene, resulting in an arg206-to-cys mutation (R206C), as the cause of late-infantile onset of neuronal ceroid lipofuscinosis-2 (CLN2; 204500) and used the mutation successfully for prenatal diagnosis, demonstrating that the fetus at risk was homozygous for the wildtype alleles. The homozygous proband had developed seizures at age 3 years and was unable to ambulate independently by age 5. Electron microscopy performed on a skin biopsy demonstrated curvilinear bodies typical of CLN2.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlinenot providednot providednot providednot providednot providednot providednot providednot provided

From UniProtKB/Swiss-Prot, SCV000091197.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providednot provided PubMed (2)
#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1not providednot provided1not providednot providednot providednot providednot providednot provided

From Natera, Inc., SCV002094863.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testingnot provided
#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

From Foundation for Research in Genetics and Endocrinology, FRIGE's Institute of Human Genetics, SCV002754481.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
11not providednot providedclinical testing PubMed (1)

Description

A Homozygous missense variation in exon 6 of the TPP1 gene that results in the amino acid substitution of Cysteine for Arginine at codon 206 was detected. The observed variant c.616C>T (p.Arg206Cys) has not been reported in the 1000 genomes and has MAF of 0.001% in gnomAD databases. The in silico prediction of the variant are possibly damaging by DANN, LRT and MutationTaster2. The reference codon is conserved across species. In summary, the variant meets our criteria to be classified as pathogenic.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineyesnot providednot providednot provided1not providednot providednot provided

From Neuberg Centre For Genomic Medicine, NCGM, SCV005060865.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (1)

Description

The observed missense c.616C>T(p.Arg206Cys) variant in TPP1 gene has been reported previously in homozygous or compound heterozygous state in individual(s) affected with Neuronal ceroid lipofuscinoses type II (NCL2) / Batten disease (Sheth et al., 2018). Experimental studies have shown that this missense change affects TPP1 function (Walus et al., 2010). This variant is reported with the allele frequency of 0.001% in the gnomAD Exomes. This variant has been reported to the ClinVar database as Pathogenic by multiple submitters. The amino acid Arg at position 206 is changed to a Cys changing protein sequence and it might alter its composition and physico-chemical properties. The amino acid change p.Arg206Cys in TPP1 is predicted as conserved by GERP++ and PhyloP across 100 vertebrates. The variant is predicted as damaging by SIFT. For these reasons, this variant has been classified as Pathogenic.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineyesnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Sep 29, 2024